Low Flux Dialysers - مدی تک سیستم

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

KOA	Surface Area (m2)	Blood priming Volume (ml)	Clearances at QB 200/300 (ml/min)					UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
KOA	Surface Area (m2)	Blood priming Volume (ml)	Inulin	Vitamine B12	Phosphate	Creatinine	Urea	UF Coefficient (Ultrafiltration)(ml/mmHg.h)	Type
637	1.0	59	-	73/78	140/158	164/196	183/231	6.8	PS 10 LF
746	1.3	69	-	86/93	150/178	176/218	191/243	8.8	PS 13 LF
1064	1.6	86	-	111/125	161/192	184/237	195/266	12.9	PS 16 LF
1292	1.8	105	-	129/144	171/211	188/259	197/276	15.5	PS 18 LF
518	1.0	59	-	91/99	134/154	155/185	171/214	8.4	PES 10 LF
629	1.3	71	-	108/121	149/176	169/207	181/230	10.4	PES 13 LF
757	1.6	90	-	117/131	158/188	178/224	188/244	12.1	PES 16 LF
1123	1.8	112	-	124/141	168/208	183/252	196/269	17	PES 18 LF

Performance data measured in vitro according to standard ISO 8637-1:2017 and ISO 86-37-2:2018

QB = 200/300 ml/min, QF=0 mi/min, T=37°C

LF= Low Flux, HF= High Flux

Purema

Unique process technology influence separation profile of membrane formation

Thicker separation

Sharpened sieving profile (S.E.T)

Optimized dialysate side distribution

Higher mechanical strength resulting in

Low albumin loss

High middle molecule removal

Maximum low molecular clearance

Undulation

:P.E.T

Performance Enhancing Technology

PET (Polyethylene terephthalate) spacer yarns consist of multifilament threads integrated into the fiber bundles

Improves dialysate distribution throughout the dialyzer

Increases clearance values
Maintains consistent performance

Throughout the entire treatment

From dialyser to dialyser

S.E.T.- Active surface management PUREMA blood

side surface

S.E.T stands for sieving Enhancing Technology

Unique patented process technology

Thicker separation layer
Unchanged ultrafiltration
More uniform pore distribution
Active surface management

Steeper sieving curve

More selective removal

Contact Us

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Purema

Undulation

:P.E.T

Performance Enhancing Technology

S.E.T.- Active surface management PUREMA blood

side surface

Click here to collaborate with us

links

Contacts

ACTIVITIES

© Meditechsys. All rights Reserved